Clinical and Translational Neuroscience Unit Feil Family Brain and Mind Research Institute and Department of Neurology Weill Cornell Medicine New York NY.
Department of Neurology University of Colorado Aurora CO.
J Am Heart Assoc. 2020 Mar 3;9(5):e015625. doi: 10.1161/JAHA.119.015625. Epub 2020 Feb 28.
Background Sex differences have been found in stroke risk factors, incidence, treatment, and outcomes. There are conflicting data on whether diagnostic evaluation for stroke may differ between men and women. Methods and Results We performed a retrospective cohort study using inpatient and outpatient claims between 2008 and 2016 from a nationally representative 5% sample of Medicare beneficiaries. We included patients ≥65 years old and hospitalized with ischemic stroke, defined by () and diagnosis codes. Logistic regression was used to determine the association between female sex and the odds of diagnostic testing and specialist evaluation, adjusted for age, race, and number of Charlson comorbidities. Among 78 822 patients with acute ischemic stroke, 58.3% (95% CI, 57.9-58.6%) were women. Female sex was associated with decreased odds of intracranial vessel imaging (odds ratio [OR]: 0.94; 95% CI, 0.91-0.97), extracranial vessel imaging (OR: 0.89; 95% CI, 0.86-0.92), heart-rhythm monitoring (OR: 0.92; 95% CI, 0.87-0.98), echocardiography (OR: 0.92; 95% CI, 0.89-0.95), evaluation by a neurologist (OR: 0.94; 95% CI, 0.91-0.97), and evaluation by a vascular neurologist (OR: 0.94; 95% CI, 0.90-0.97), after adjustment for age, race, and comorbidities. These findings were unchanged in separate sensitivity analyses excluding patients who died during the index hospitalization or were discharged to hospice and excluding patients with atrial fibrillation diagnosed before their index stroke. Conclusions In a nationally representative cohort of Medicare beneficiaries, we found that women with acute ischemic stroke were less likely to be evaluated by stroke specialists and less likely to undergo standard diagnostic testing compared with men.
在中风风险因素、发病、治疗和预后方面存在性别差异。关于诊断评估是否存在男女差异,目前数据存在冲突。
我们使用了一项回顾性队列研究,该研究基于 2008 年至 2016 年来自医疗保险受益人群的全国代表性的 5%样本中的住院和门诊索赔数据。我们纳入了年龄≥65 岁并因缺血性中风住院的患者,其定义为()和诊断代码。我们使用逻辑回归来确定女性性别与诊断测试和专家评估的几率之间的关联,调整了年龄、种族和 Charlson 合并症的数量。在 78822 名急性缺血性中风患者中,58.3%(95%置信区间,57.9-58.6%)为女性。女性性别与颅内血管成像的几率降低相关(比值比[OR]:0.94;95%置信区间,0.91-0.97)、颅外血管成像(OR:0.89;95%置信区间,0.86-0.92)、心脏节律监测(OR:0.92;95%置信区间,0.87-0.98)、超声心动图(OR:0.92;95%置信区间,0.89-0.95)、神经科医生评估(OR:0.94;95%置信区间,0.91-0.97)和血管神经病学专家评估(OR:0.94;95%置信区间,0.90-0.97),在调整年龄、种族和合并症后。在单独的敏感性分析中,排除索引住院期间死亡或出院到临终关怀的患者以及排除在索引中风前诊断为房颤的患者后,这些发现保持不变。
在医疗保险受益人群的全国代表性队列中,我们发现与男性相比,急性缺血性中风的女性更不可能接受中风专家评估,也更不可能接受标准诊断测试。